Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 1 Polycystic Ovary Syndrome 1 Non-alcoholic Fatty Liver Disease 1 Multiple Myeloma 1 Growth Hormone-Secreting Pituitary Adenoma 1 Glioblastoma 1 Fatty Liver 1 Drug Resistant Epilepsy 1 Breast Neoplasms 1 Brain Neoplasms 1 Autism Spectrum Disorder 1 Adenocarcinoma of Lung 1

Interventions

Pemetrexed 6 pembrolizumab 5 Magnetic Resonance Spectroscopy 5 Carboplatin 5 Specimen Handling 4 Mastectomy, Segmental 4 Cisplatin 4 Bevacizumab 4 durvalumab 2 Platinum 2 Biopsy 2 tislelizumab 1 osimertinib 1 methyl-4-fluoro-4-deoxyglucose 1 methoxyamine 1 fludarabine phosphate 1 devimistat 1 dehydroftorafur 1 defactinib 1 dapagliflozin 1 capmatinib 1 aflutinib 1 Standard of Care 1 Smoking Devices 1 Radiotherapy 1 Radiation 1 RO5126766 1 Practice Guidelines as Topic 1 Observation 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Adenocarcinoma of Lung × Diet, Ketogenic × Clear all

NCT07479095 2026-03-20

KETO-FDG Lung

Fondazione del Piemonte per l'Oncologia

Phase NA Recruiting

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡